IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $14,480,000 | +136.5% | 178,392 | +57.5% | 0.01% | +100.0% |
| Q4 2018 | $6,123,000 | -80.0% | 113,258 | -81.0% | 0.01% | -50.0% |
| Q3 2018 | $30,680,000 | +142.5% | 594,806 | +95.9% | 0.01% | +11.1% |
| Q2 2018 | $12,651,000 | -7.8% | 303,607 | -2.5% | 0.01% | 0.0% |
| Q1 2018 | $13,723,000 | -15.1% | 311,327 | -3.1% | 0.01% | -18.2% |
| Q4 2017 | $16,155,000 | -5.8% | 321,178 | -5.0% | 0.01% | -8.3% |
| Q3 2017 | $17,147,000 | -7.6% | 338,205 | -7.2% | 0.01% | -7.7% |
| Q2 2017 | $18,548,000 | +28.4% | 364,617 | +1.4% | 0.01% | +30.0% |
| Q1 2017 | $14,450,000 | -17.8% | 359,449 | -2.2% | 0.01% | -23.1% |
| Q4 2016 | $17,587,000 | +25.3% | 367,700 | -4.0% | 0.01% | +44.4% |
| Q3 2016 | $14,039,000 | +66.2% | 383,160 | +5.7% | 0.01% | +50.0% |
| Q2 2016 | $8,446,000 | -42.7% | 362,639 | -0.4% | 0.01% | -45.5% |
| Q1 2016 | $14,742,000 | -37.6% | 363,996 | -4.6% | 0.01% | -38.9% |
| Q4 2015 | $23,622,000 | – | 381,431 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |